Web Date: June 7, 2006
FDA Approves Resumed Sale Of MS Drug
A multiple sclerosis (MS) drug withdrawn from the market for a year because of a rare but serious side effect will be allowed to return under a restricted distribution program designed to help ensure safe use of the product, federal health officials said on June 5.
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society